For research use only. Not for therapeutic Use.
(R)-Brompheniramine(CAT: I023732) is the enantiomerically pure form of brompheniramine, a first-generation antihistamine that selectively antagonizes H1 histamine receptors. This compound is widely used in pharmacological research to study histamine-mediated allergic responses, including rhinitis, conjunctivitis, and urticaria. The (R)-enantiomer exhibits enhanced receptor affinity and activity, making it valuable for exploring stereospecific interactions with histamine receptors. With high purity and stability, (R)-Brompheniramine is suitable for in vitro and in vivo studies, supporting advancements in the development of antihistamines and the understanding of stereoisomer-specific pharmacodynamics in allergic and inflammatory conditions.
Catalog Number | I023732 |
CAS Number | 32656-44-3 |
Synonyms | Brompheniramine, (R)-; Dimetapp; (-)-Brompheniramine; (R)-Brompheniramine; L-Brompheniramine |
Molecular Formula | C16H19BrN2 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | (3R)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine |
InChI | InChI=1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3/t15-/m1/s1 |
InChIKey | ZDIGNSYAACHWNL-OAHLLOKOSA-N |
SMILES | CN(C)CC[C@H](C1=CC=C(C=C1)Br)C2=CC=CC=N2 |